Evaluating Biocompatibility: From Classical Techniques to State-of-the-Art Functional Proteomics

Ana Nuño-Soriano1,2, Carlota Arias-Hidalgo1,2, Enrique Montalvillo1

  • 1Translational and Clinical Research Program, Cytometry Service, NUCLEUS and Department of Medicine, Cancer Center Research (IBMSS-CSIC), University of Salamanca, 37008 Salamanca, Spain.

Summary

Evaluating biomaterial biocompatibility is crucial for clinical use. High-throughput functional proteomics, using protein microarrays and mass spectrometry, offers advanced methods for assessing safety and cellular interactions.